Award a prize of around £3 million to the first group that can develop an interface that takes raw metagenomics data and turns out potentially clinically relevant results.
Clinical metagenomics has the potential to identify new, unexpected pathogens in the first few infected patients, rather than months later. This would be game-changing, as it would allow for a much earlier, targeted response to an outbreak of an unknown virus.
